Global Bone Metastasis Market Research Report 2023

Bone metastases, or osseous metastatic disease, is a category of cancer metastases that results from primary tumor invasion to bone. Bone-originating primary tumors such as osteosarcoma, chondrosarcoma, and Ewing's sarcoma are rare.

The global Bone Metastasis market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Bone Metastasis is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Bone Metastasis is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Bone Metastasis in Hospitals is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Bone Metastasis include Roche, Bayer, Merck & Co, Pfizer, Novartis, Amgen, Pharmalucence, Fresenius Kabi and Omega Laboratories, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Bone Metastasis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bone Metastasis.

The Bone Metastasis market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Bone Metastasis market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Bone Metastasis companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Bone Metastasis Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Pain Relievers

1.2.3 Bone Building Medications

1.2.4 Targeted Therapy Agents

1.3 Market by Application

1.3.1 Global Bone Metastasis Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Hospitals

1.3.3 Cancer Rehabilitation Centers

1.3.4 Specialty Clinics

1.3.5 Ambulatory Surgical Centers

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Bone Metastasis Market Perspective (2018-2029)

2.2 Bone Metastasis Growth Trends by Region

2.2.1 Global Bone Metastasis Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Bone Metastasis Historic Market Size by Region (2018-2023)

2.2.3 Bone Metastasis Forecasted Market Size by Region (2024-2029)

2.3 Bone Metastasis Market Dynamics

2.3.1 Bone Metastasis Industry Trends

2.3.2 Bone Metastasis Market Drivers

2.3.3 Bone Metastasis Market Challenges

2.3.4 Bone Metastasis Market Restraints

3.1 Global Top Bone Metastasis Players by Revenue

3.1.1 Global Top Bone Metastasis Players by Revenue (2018-2023)

3.1.2 Global Bone Metastasis Revenue Market Share by Players (2018-2023)

3.2 Global Bone Metastasis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Bone Metastasis Revenue

3.4 Global Bone Metastasis Market Concentration Ratio

3.4.1 Global Bone Metastasis Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Bone Metastasis Revenue in 2022

3.5 Bone Metastasis Key Players Head office and Area Served

3.6 Key Players Bone Metastasis Product Solution and Service

3.7 Date of Enter into Bone Metastasis Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Bone Metastasis Historic Market Size by Type (2018-2023)

4.2 Global Bone Metastasis Forecasted Market Size by Type (2024-2029)

5.1 Global Bone Metastasis Historic Market Size by Application (2018-2023)

5.2 Global Bone Metastasis Forecasted Market Size by Application (2024-2029)

6.1 North America Bone Metastasis Market Size (2018-2029)

6.2 North America Bone Metastasis Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Bone Metastasis Market Size by Country (2018-2023)

6.4 North America Bone Metastasis Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Bone Metastasis Market Size (2018-2029)

7.2 Europe Bone Metastasis Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Bone Metastasis Market Size by Country (2018-2023)

7.4 Europe Bone Metastasis Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Bone Metastasis Market Size (2018-2029)

8.2 Asia-Pacific Bone Metastasis Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Bone Metastasis Market Size by Region (2018-2023)

8.4 Asia-Pacific Bone Metastasis Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Bone Metastasis Market Size (2018-2029)

9.2 Latin America Bone Metastasis Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Bone Metastasis Market Size by Country (2018-2023)

9.4 Latin America Bone Metastasis Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Bone Metastasis Market Size (2018-2029)

10.2 Middle East & Africa Bone Metastasis Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Bone Metastasis Market Size by Country (2018-2023)

10.4 Middle East & Africa Bone Metastasis Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Roche

11.1.1 Roche Company Detail

11.1.2 Roche Business Overview

11.1.3 Roche Bone Metastasis Introduction

11.1.4 Roche Revenue in Bone Metastasis Business (2018-2023)

11.1.5 Roche Recent Development

11.2 Bayer

11.2.1 Bayer Company Detail

11.2.2 Bayer Business Overview

11.2.3 Bayer Bone Metastasis Introduction

11.2.4 Bayer Revenue in Bone Metastasis Business (2018-2023)

11.2.5 Bayer Recent Development

11.3 Merck & Co

11.3.1 Merck & Co Company Detail

11.3.2 Merck & Co Business Overview

11.3.3 Merck & Co Bone Metastasis Introduction

11.3.4 Merck & Co Revenue in Bone Metastasis Business (2018-2023)

11.3.5 Merck & Co Recent Development

11.4 Pfizer

11.4.1 Pfizer Company Detail

11.4.2 Pfizer Business Overview

11.4.3 Pfizer Bone Metastasis Introduction

11.4.4 Pfizer Revenue in Bone Metastasis Business (2018-2023)

11.4.5 Pfizer Recent Development

11.5 Novartis

11.5.1 Novartis Company Detail

11.5.2 Novartis Business Overview

11.5.3 Novartis Bone Metastasis Introduction

11.5.4 Novartis Revenue in Bone Metastasis Business (2018-2023)

11.5.5 Novartis Recent Development

11.6 Amgen

11.6.1 Amgen Company Detail

11.6.2 Amgen Business Overview

11.6.3 Amgen Bone Metastasis Introduction

11.6.4 Amgen Revenue in Bone Metastasis Business (2018-2023)

11.6.5 Amgen Recent Development

11.7 Pharmalucence

11.7.1 Pharmalucence Company Detail

11.7.2 Pharmalucence Business Overview

11.7.3 Pharmalucence Bone Metastasis Introduction

11.7.4 Pharmalucence Revenue in Bone Metastasis Business (2018-2023)

11.7.5 Pharmalucence Recent Development

11.8 Fresenius Kabi

11.8.1 Fresenius Kabi Company Detail

11.8.2 Fresenius Kabi Business Overview

11.8.3 Fresenius Kabi Bone Metastasis Introduction

11.8.4 Fresenius Kabi Revenue in Bone Metastasis Business (2018-2023)

11.8.5 Fresenius Kabi Recent Development

11.9 Omega Laboratories

11.9.1 Omega Laboratories Company Detail

11.9.2 Omega Laboratories Business Overview

11.9.3 Omega Laboratories Bone Metastasis Introduction

11.9.4 Omega Laboratories Revenue in Bone Metastasis Business (2018-2023)

11.9.5 Omega Laboratories Recent Development

11.10 Eli Lilly and Company

11.10.1 Eli Lilly and Company Company Detail

11.10.2 Eli Lilly and Company Business Overview

11.10.3 Eli Lilly and Company Bone Metastasis Introduction

11.10.4 Eli Lilly and Company Revenue in Bone Metastasis Business (2018-2023)

11.10.5 Eli Lilly and Company Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Bone Metastasis Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Pain Relievers

    Table 3. Key Players of Bone Building Medications

    Table 4. Key Players of Targeted Therapy Agents

    Table 5. Global Bone Metastasis Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 6. Global Bone Metastasis Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 7. Global Bone Metastasis Market Size by Region (2018-2023) & (US$ Million)

    Table 8. Global Bone Metastasis Market Share by Region (2018-2023)

    Table 9. Global Bone Metastasis Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 10. Global Bone Metastasis Market Share by Region (2024-2029)

    Table 11. Bone Metastasis Market Trends

    Table 12. Bone Metastasis Market Drivers

    Table 13. Bone Metastasis Market Challenges

    Table 14. Bone Metastasis Market Restraints

    Table 15. Global Bone Metastasis Revenue by Players (2018-2023) & (US$ Million)

    Table 16. Global Bone Metastasis Market Share by Players (2018-2023)

    Table 17. Global Top Bone Metastasis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bone Metastasis as of 2022)

    Table 18. Ranking of Global Top Bone Metastasis Companies by Revenue (US$ Million) in 2022

    Table 19. Global 5 Largest Players Market Share by Bone Metastasis Revenue (CR5 and HHI) & (2018-2023)

    Table 20. Key Players Headquarters and Area Served

    Table 21. Key Players Bone Metastasis Product Solution and Service

    Table 22. Date of Enter into Bone Metastasis Market

    Table 23. Mergers & Acquisitions, Expansion Plans

    Table 24. Global Bone Metastasis Market Size by Type (2018-2023) & (US$ Million)

    Table 25. Global Bone Metastasis Revenue Market Share by Type (2018-2023)

    Table 26. Global Bone Metastasis Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 27. Global Bone Metastasis Revenue Market Share by Type (2024-2029)

    Table 28. Global Bone Metastasis Market Size by Application (2018-2023) & (US$ Million)

    Table 29. Global Bone Metastasis Revenue Market Share by Application (2018-2023)

    Table 30. Global Bone Metastasis Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 31. Global Bone Metastasis Revenue Market Share by Application (2024-2029)

    Table 32. North America Bone Metastasis Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 33. North America Bone Metastasis Market Size by Country (2018-2023) & (US$ Million)

    Table 34. North America Bone Metastasis Market Size by Country (2024-2029) & (US$ Million)

    Table 35. Europe Bone Metastasis Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 36. Europe Bone Metastasis Market Size by Country (2018-2023) & (US$ Million)

    Table 37. Europe Bone Metastasis Market Size by Country (2024-2029) & (US$ Million)

    Table 38. Asia-Pacific Bone Metastasis Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 39. Asia-Pacific Bone Metastasis Market Size by Region (2018-2023) & (US$ Million)

    Table 40. Asia-Pacific Bone Metastasis Market Size by Region (2024-2029) & (US$ Million)

    Table 41. Latin America Bone Metastasis Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 42. Latin America Bone Metastasis Market Size by Country (2018-2023) & (US$ Million)

    Table 43. Latin America Bone Metastasis Market Size by Country (2024-2029) & (US$ Million)

    Table 44. Middle East & Africa Bone Metastasis Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 45. Middle East & Africa Bone Metastasis Market Size by Country (2018-2023) & (US$ Million)

    Table 46. Middle East & Africa Bone Metastasis Market Size by Country (2024-2029) & (US$ Million)

    Table 47. Roche Company Detail

    Table 48. Roche Business Overview

    Table 49. Roche Bone Metastasis Product

    Table 50. Roche Revenue in Bone Metastasis Business (2018-2023) & (US$ Million)

    Table 51. Roche Recent Development

    Table 52. Bayer Company Detail

    Table 53. Bayer Business Overview

    Table 54. Bayer Bone Metastasis Product

    Table 55. Bayer Revenue in Bone Metastasis Business (2018-2023) & (US$ Million)

    Table 56. Bayer Recent Development

    Table 57. Merck & Co Company Detail

    Table 58. Merck & Co Business Overview

    Table 59. Merck & Co Bone Metastasis Product

    Table 60. Merck & Co Revenue in Bone Metastasis Business (2018-2023) & (US$ Million)

    Table 61. Merck & Co Recent Development

    Table 62. Pfizer Company Detail

    Table 63. Pfizer Business Overview

    Table 64. Pfizer Bone Metastasis Product

    Table 65. Pfizer Revenue in Bone Metastasis Business (2018-2023) & (US$ Million)

    Table 66. Pfizer Recent Development

    Table 67. Novartis Company Detail

    Table 68. Novartis Business Overview

    Table 69. Novartis Bone Metastasis Product

    Table 70. Novartis Revenue in Bone Metastasis Business (2018-2023) & (US$ Million)

    Table 71. Novartis Recent Development

    Table 72. Amgen Company Detail

    Table 73. Amgen Business Overview

    Table 74. Amgen Bone Metastasis Product

    Table 75. Amgen Revenue in Bone Metastasis Business (2018-2023) & (US$ Million)

    Table 76. Amgen Recent Development

    Table 77. Pharmalucence Company Detail

    Table 78. Pharmalucence Business Overview

    Table 79. Pharmalucence Bone Metastasis Product

    Table 80. Pharmalucence Revenue in Bone Metastasis Business (2018-2023) & (US$ Million)

    Table 81. Pharmalucence Recent Development

    Table 82. Fresenius Kabi Company Detail

    Table 83. Fresenius Kabi Business Overview

    Table 84. Fresenius Kabi Bone Metastasis Product

    Table 85. Fresenius Kabi Revenue in Bone Metastasis Business (2018-2023) & (US$ Million)

    Table 86. Fresenius Kabi Recent Development

    Table 87. Omega Laboratories Company Detail

    Table 88. Omega Laboratories Business Overview

    Table 89. Omega Laboratories Bone Metastasis Product

    Table 90. Omega Laboratories Revenue in Bone Metastasis Business (2018-2023) & (US$ Million)

    Table 91. Omega Laboratories Recent Development

    Table 92. Eli Lilly and Company Company Detail

    Table 93. Eli Lilly and Company Business Overview

    Table 94. Eli Lilly and Company Bone Metastasis Product

    Table 95. Eli Lilly and Company Revenue in Bone Metastasis Business (2018-2023) & (US$ Million)

    Table 96. Eli Lilly and Company Recent Development

    Table 97. Research Programs/Design for This Report

    Table 98. Key Data Information from Secondary Sources

    Table 99. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Bone Metastasis Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Bone Metastasis Market Share by Type: 2022 VS 2029

    Figure 3. Pain Relievers Features

    Figure 4. Bone Building Medications Features

    Figure 5. Targeted Therapy Agents Features

    Figure 6. Global Bone Metastasis Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 7. Global Bone Metastasis Market Share by Application: 2022 VS 2029

    Figure 8. Hospitals Case Studies

    Figure 9. Cancer Rehabilitation Centers Case Studies

    Figure 10. Specialty Clinics Case Studies

    Figure 11. Ambulatory Surgical Centers Case Studies

    Figure 12. Bone Metastasis Report Years Considered

    Figure 13. Global Bone Metastasis Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 14. Global Bone Metastasis Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 15. Global Bone Metastasis Market Share by Region: 2022 VS 2029

    Figure 16. Global Bone Metastasis Market Share by Players in 2022

    Figure 17. Global Top Bone Metastasis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bone Metastasis as of 2022)

    Figure 18. The Top 10 and 5 Players Market Share by Bone Metastasis Revenue in 2022

    Figure 19. North America Bone Metastasis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 20. North America Bone Metastasis Market Share by Country (2018-2029)

    Figure 21. United States Bone Metastasis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Canada Bone Metastasis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Europe Bone Metastasis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. Europe Bone Metastasis Market Share by Country (2018-2029)

    Figure 25. Germany Bone Metastasis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. France Bone Metastasis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. U.K. Bone Metastasis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Italy Bone Metastasis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Russia Bone Metastasis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Nordic Countries Bone Metastasis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Asia-Pacific Bone Metastasis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Asia-Pacific Bone Metastasis Market Share by Region (2018-2029)

    Figure 33. China Bone Metastasis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Japan Bone Metastasis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. South Korea Bone Metastasis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Southeast Asia Bone Metastasis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. India Bone Metastasis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Australia Bone Metastasis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Latin America Bone Metastasis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Latin America Bone Metastasis Market Share by Country (2018-2029)

    Figure 41. Mexico Bone Metastasis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Brazil Bone Metastasis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Middle East & Africa Bone Metastasis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Middle East & Africa Bone Metastasis Market Share by Country (2018-2029)

    Figure 45. Turkey Bone Metastasis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Saudi Arabia Bone Metastasis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Roche Revenue Growth Rate in Bone Metastasis Business (2018-2023)

    Figure 48. Bayer Revenue Growth Rate in Bone Metastasis Business (2018-2023)

    Figure 49. Merck & Co Revenue Growth Rate in Bone Metastasis Business (2018-2023)

    Figure 50. Pfizer Revenue Growth Rate in Bone Metastasis Business (2018-2023)

    Figure 51. Novartis Revenue Growth Rate in Bone Metastasis Business (2018-2023)

    Figure 52. Amgen Revenue Growth Rate in Bone Metastasis Business (2018-2023)

    Figure 53. Pharmalucence Revenue Growth Rate in Bone Metastasis Business (2018-2023)

    Figure 54. Fresenius Kabi Revenue Growth Rate in Bone Metastasis Business (2018-2023)

    Figure 55. Omega Laboratories Revenue Growth Rate in Bone Metastasis Business (2018-2023)

    Figure 56. Eli Lilly and Company Revenue Growth Rate in Bone Metastasis Business (2018-2023)

    Figure 57. Bottom-up and Top-down Approaches for This Report

    Figure 58. Data Triangulation

    Figure 59. Key Executives Interviewed